Epibiotech Co., Ltd. (XKON:446440)
14,840
+200 (1.37%)
At close: Dec 12, 2025
-1.07% (1Y)
| Market Cap | 34.23B |
| Revenue (ttm) | 449.62M |
| Net Income (ttm) | -5.06B |
| Shares Out | 2.31M |
| EPS (ttm) | -2,966.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 951 |
| Average Volume | 385 |
| Open | 14,010 |
| Previous Close | 14,640 |
| Day's Range | 14,000 - 15,500 |
| 52-Week Range | 9,600 - 19,000 |
| Beta | 1.26 |
| RSI | 43.71 |
| Earnings Date | n/a |